Clinical trial
Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic…
NCT00486187 · Dr. Milan Gupta, Other · Completed
Key facts
| NCT number | NCT00486187 |
|---|---|
| Title | Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study |
| Official title | Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study |
| Lead sponsor | Dr. Milan Gupta, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | rosiglitazone, metformin or sulfonylurea |
| Enrollment | 103 |
| Start date | Apr 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Jun 14, 2007 |
| Last update posted | Jan 28, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: